The trademark application PST was filed by Adaptive Phage Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 14, 2023, and it was registered by office on September 21, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
New product research and development in the fields of personalized medicine and diagnostics
Data mining of healthcare and genetic information in the field of precision medicine and personalized medicine
Scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and pharmaceuticals
Medical laboratory services and scientific laboratory services in the nature of clinical and medical laboratory services for medical research purposes in the fields of disease diagnostics and personalized medicine
Pharmaceutical drug research and development
Custom biochemical assay development
Pharmaceutical drug discovery and development services
Providing laboratory research services in the field of medical diagnostics and personalized medicine
Medical research services
Biotechnology research
Providing medical and scientific research information in the field of clinical trials
New product research and development of vaccines and therapeutics
Providing temporary use of online non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections
Medical research, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes
Development of new technology for others in the field of biotechnology
Laboratory research in the field of genomic sequencing
Research and development in the pharmaceutical and biotechnology fields
Research development, engineering and testing services in the fields of bacteria and viruses
Laboratory research in the field of infectious diseases
Medical and scientific research in the field of immunotherapy
Laboratory research services in the field of microbiological laboratory testing of bacteria for research purposes and technical consultation relating thereto
Scientific and medical research, in particular, design and development of diagnostic assays.
The mark was filed in class 44 with following description of goods:
Medical testing for diagnostic or treatment purposes in the field of personalized medicine
Health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes
Medical testing for diagnostic or treatment purposes, namely, providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly
Medical services
Medical consulting services in the field of medical diagnostic and prognostic testing
Medical services in the nature of medical analysis services for diagnostic and prognostic testing and treatment purposes
Medical analysis services relating to the diagnosis and treatment of a person
Medical testing and medical diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
Medical laboratory services
Medical laboratory services in the nature of testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine
Medical laboratory services in the nature of microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto.